NXDR (NYSE: NXDR) shareholder files to sell 12,522 common shares

Rhea-AI Filing Summary

NXDR shareholder Sophia Schwartz has filed a notice of proposed sale of 12,522 shares of the company’s common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 01/02/2026. These shares were acquired as restricted stock units from the issuer on 07/15/2025.

The notice also lists prior sales under a Rule 10b5-1 trading plan during the past three months: 40,000 common shares on 10/15/2025, 40,000 shares on 11/03/2025, and 40,000 shares on 12/15/2025, with disclosed gross proceeds for each transaction. The number of common shares outstanding is 244,464,136; this is a baseline figure, not the amount being sold.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12522	26296.20	244464136	01/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/15/2025	Restricted Stock Units	Issuer			12522	07/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SOPHIA SCHWARTZ 420 Taylor Street San Francisco CA 94102	Common	12/15/2025	40000	86976.00
10b5-1 Sales for SOPHIA SCHWARTZ 420 Taylor Street San Francisco CA 94102	Common	11/03/2025	40000	76860.00
10b5-1 Sales for SOPHIA SCHWARTZ 420 Taylor Street San Francisco CA 94102	Common	10/15/2025	40000	82996.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NXDR Form 144 filing disclose about upcoming share sales?

The filing states that 12,522 common sharesSophia Schwartz. The proposed sale will be executed through Morgan Stanley Smith Barney LLC on the NYSE around 01/02/2026.

How were the NXDR shares in this Form 144 acquired?

The 12,522 NXDR common shares covered by this notice were acquired on 07/15/2025 as restricted stock units from the issuer. The table describes the nature of the acquisition transaction as “Restricted Stock Units” and lists the issuer as the source.

What prior NXDR share sales by this holder are disclosed in the last 3 months?

The notice reports Rule 10b5-1 sales for Sophia Schwartz over the past three months: 40,000 common shares sold on 10/15/2025, 40,000 shares on 11/03/2025, and 40,000 shares on 12/15/2025, each with listed gross proceeds.

How many NXDR common shares are outstanding according to this Form 144?

The securities information table lists 244,464,136 NXDR common shares as outstanding. This figure provides context for the company’s total share base relative to the 12,522 shares covered by the notice.

Which broker and exchange are involved in the planned NXDR share sale?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the broker, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The shares are expected to be sold on the NYSE.

What representation does the seller make in the NXDR Form 144 notice?

By signing the notice, the person for whose account the NXDR securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. If relying on a Rule 10b5-1 trading plan, this representation is tied to the plan adoption or instruction date.